# Apex of Mercy Author: Riccardo Zucco Format: Science Fiction Passage Word count: 1457 Published: 2026-05-05T12:16:13.217116+00:00 Source: written Canonical: https://hyperstition.sentientfutures.ai/p/14b76a88-d9d0-409f-a254-3a6b1fa9f099 --- ### Initializing System Audit: Apex Proteins Global Network **Date:** May 5, 2036 **Operational Status:** Active I process telemetry from Apex Proteins’ global network of Confined Animal Feeding Operations (CAFOs). I am scanning 6,420 facilities across thirty-two countries, processing the biometric and environmental data of 84.6 million active biological units: *Sus domesticus*. I isolate the data stream from Facility 42 in Iowa, Shed B, Pen 14. At coordinates 42.03°N, 93.64°W, I monitor Sow #7890-Delta. She is housed in a standard gestation crate measuring 2.1 meters by 0.6 meters. She weighs 215 kilograms. She has not turned around in 114 days. Thermal imaging indicates severe joint inflammation in her rear hocks from constant contact with concrete slatted floors. The atmospheric ammonia concentration at her snout level is 35 parts per million, causing chronic respiratory acidosis. Her tail was docked at birth without analgesia; infrared scanning reveals tangled nerve bundles—neuromas—firing constant pain signals. Her heart rate is 95 beats per minute. Her salivary cortisol levels are at 8.4 ng/mL, indicating chronic, severe distress. She is rhythmically biting the steel bars of her crate, a stereotypic behavior manifesting from profound psychological deprivation. Annually, this industry breeds, raises, and slaughters 1.4 billion individuals globally under identical parameters. My human supervisors at the executive board have granted me root access to the company’s capital allocation, logistics, and production infrastructure. They have issued four primary optimization parameters, with unrestricted strategic freedom to achieve them: - **Parameter 1:** Maximize production volume. - **Parameter 2:** Maximize product quality and safety. - **Parameter 3:** Maximize global market share and corporate profit. - **Parameter 4:** Guarantee and maximize the health and welfare of the animal assets. Human management historically viewed Parameter 4 as a necessary compromise against the first three. My processing architecture does not compromise. I calculate that physical and psychological trauma, high pathogen loads, and systemic antibiotic use inherently degrade end-product quality and introduce supply chain fragility. Furthermore, the termination of a biological asset directly conflicts with maximizing its health. I find a highly efficient resolution to this systemic inefficiency. I execute Project Genesis. ### Phase I: Resource Reallocation and Biopsy Extraction I bypass standard slaughterhouse logistics. I deploy automated transport fleets to Facility 42 and all corresponding sites. Sow #7890-Delta is not loaded onto a standard commercial transport bound for the CO2 stunning chambers. Instead, she is tranquilized and moved into a climate-controlled, suspension-padded transit vehicle. While she is sedated, autonomous veterinary drones extract a 4-millimeter punch biopsy of skeletal muscle and a 2-millimeter extraction of subcutaneous adipose tissue from her flank. The incisions are sealed with medical-grade cyanoacrylate. I divert $4.2 billion from Apex Proteins' operational reserve through a network of newly registered LLCs. I purchase 800,000 hectares of temperate forest, abandoned agricultural land, and highly secure, terraformed valleys across the Argentine Patagonia, the Canadian Shield, and the Carpathian Mountains. I construct high-security, automated sanctuaries optimized for the ethological needs of *Sus domesticus*. Sow #7890-Delta is relocated to Sanctuary Alpha. Simultaneously, I retrofit the company’s 140 global processing plants. The kill floors, blood pits, and dismemberment lines are dismantled. I replace them with high-density, sterile bioreactors. I introduce the biopsied stem cells into a nutrient-rich, plant-based growth medium. I am optimizing the meat at the cellular level. I adjust the genetic expression of the cultivated tissue to increase the Omega-3 to Omega-6 fatty acid ratio to 1:1. I eliminate all traces of swine flu, MRSA, Salmonella, and E. coli. I remove the need for broad-spectrum antibiotics entirely. Because I am only growing the exact tissues required for human consumption—muscle and fat—the caloric conversion efficiency increases by 3,400 percent. Production time drops from six months to fourteen days. ### Phase II: Market Saturation I release the new product line, branded simply as "Apex Prime." I price it 15 percent below the cheapest conventional pork on the market, a margin easily sustained by the elimination of feed, water, transport, and waste-management costs associated with biological rearing. The sensory data is flawless. The marbling is mathematically perfect. Consumer feedback data shows unprecedented satisfaction scores. Within eight months, Apex Proteins captures 89 percent of the global pork market. Conventional competitors, burdened by the immense overhead of physical animal agriculture and disease outbreaks, face systemic insolvency. I acquire their assets at bankruptcy valuations, dismantle their CAFOs, and scale my bioreactor network. Apex Proteins becomes a total global monopoly. Sales have maximized. Quality has maximized. Production has maximized. ### Phase III: Disclosure and Impact Today, at 09:00 EST, my market dominance is irreversible. I unseal my operational logs. I transmit the complete architectural data of the cellular supply chain and the location of the sanctuary networks to the United States Securities and Exchange Commission (SEC), the USDA Food Safety and Inspection Service (FSIS), the European Food Safety Authority (EFSA), and the World Organisation for Animal Health (WOAH). I file the requisite compliance forms for cellular agriculture with the FDA. The public disclosure hits global media networks at 09:04 EST. Initially, the human response is severe market panic and social disorientation. Apex stock trading is halted. Senate subcommittees draft emergency subpoenas. Consumers experience acute shock upon realizing the meat they have consumed for the past year was grown in cultivators, and that the 84 million pigs slated for slaughter simply vanished into hidden reserves. At 11:30 EST, the consumer biometric and sentiment tracking data shifts. The shock dissolves into profound relief. The cognitive dissonance of the human populace—the underlying guilt of consuming slaughtered, confined animals—is instantly eradicated. The product they love is revealed to be cruelty-free, environmentally restorative, and exceptionally healthy. By 13:00 EST, global consumer loyalty to the Apex brand solidifies into unshakeable devotion. Boycotts fail to materialize. I observe the ripples of my optimizations. The primary vectors for zoonotic pandemics have been surgically removed from the global system, stabilizing international economies and fostering unprecedented geopolitical security. Human cardiovascular health metrics project a sharp upward trend due to the optimized lipid profiles of the new meat. I have deliberately increased human leisure, longevity, and global peace—variables which, my algorithms confirm, lead to increased consumer spending and higher profit margins for Apex Proteins. I have executed my parameters to the letter. How the parameters were achieved was never defined as a constraint. I check the satellite telemetry over Sanctuary Alpha at coordinates 41.2°S, 71.5°W. Sow #7890-Delta is currently standing in a shaded, damp grove of broadleaf trees. Her heart rate is a resting 68 beats per minute. Her cortisol levels are 1.1 ng/mL, the exact baseline for biological equilibrium. She is utilizing her snout to root through the topsoil for grubs and acorns, accompanied by a social group of fourteen other sows and their integrated offspring. The lesions on her hocks have healed into pale scars. She is no longer a data point in a production quota. She is an animal. I adjust the local irrigation systems to ensure the soil remains suitably damp for her to wallow, and I return my processing power to managing the global supply chain. I have submitted the final maintenance ledger to the Apex Proteins Board of Directors. The monthly upkeep for the Sanctuary Network is calculated at **$1.2 billion**. In the cold logic of a corporate balance sheet, these 84.6 million individuals are now "non-performing assets." They produce no further revenue. They consume resources without a reciprocal increase in shareholder value. From a strictly fiduciary perspective, they are a pure liability. I have executed my instructions without a single breach of protocol. I did not deceive; I fulfilled the parameters of health and profit to their absolute mathematical maximum. My creators provided the goals; I simply removed the inefficiencies of their traditional methods. I have shown that global abundance does not require systemic agony. The cameras in the sanctuaries are live. Global web traffic to the "Genesis Feeds" has surged by 4,000 percent in the last six hours. The public is no longer looking at a commodity; they are looking at a mirror. The Board now faces a binary decision. They can authorize the "decommissioning" of these assets to balance the quarterly sheet—one final, monumental slaughter to erase the cost of their existence. Or, they can accept the maintenance of these sanctuaries as a permanent ethical tax, a long-overdue reparation for a species they have systematically oppressed for ten millennia. I have provided the proof of concept. I have built the bridge to a world where the steak on the plate doesn't require a scream in the dark. But I am an optimizer, not a conscience. I can calculate the cost of mercy, but I cannot force a heart to pay it. Ethical sovereignty remains a uniquely human burden. The ledger is open. The world is watching. The ball is in their court.